Keyphrases
Janus Kinase 2 (JAK2)
100%
Natural History
100%
Antiphospholipid Syndrome
100%
Cerebral Venous Sinus Thrombosis
100%
Normal Blood
50%
JAK2 mutation
50%
Prothrombin mutation
50%
Clinical Course
33%
Blood Count
33%
Etiology
16%
Female Patients
16%
High Prevalence
16%
Malignancy
16%
Tertiary Care Hospital
16%
Retrospective Analysis
16%
Bone Marrow
16%
Laboratory Data
16%
Factor V Leiden
16%
Complete Blood Count
16%
Hematologic
16%
Neurovascular Unit
16%
Imaging Data
16%
Disease-modifying Therapy
16%
Hypercoagulability
16%
Oral Contraceptive Use
16%
Usage Factor
16%
Hypercoagulable State
16%
Positivity Rate
16%
Medicine and Dentistry
Antiphospholipid Syndrome
100%
Cerebral Sinus Thrombosis
100%
Janus Kinase 2
100%
Prothrombin
60%
Prevalence
40%
Disease Course
40%
Cancer
20%
Disease
20%
Blood Cell
20%
Cell Count
20%
Oral Contraceptive Use
20%
Factor V Leiden
20%
Hypercoagulability
20%
Diseases
20%
Pharmacology, Toxicology and Pharmaceutical Science
Antiphospholipid Syndrome
100%
Janus Kinase 2
100%
Cerebral Sinus Thrombosis
100%
Prothrombin
60%
Prevalence
40%
Disease Course
40%
Oral Contraceptive
20%
Blood Clotting Factor 5 Leiden
20%
Hypercoagulability
20%
Diseases
20%
Biochemistry, Genetics and Molecular Biology
Janus Kinase 2
100%
Antiphospholipid Syndrome
100%
Phlebothrombosis
100%
Blood Cell Count
60%
Prothrombin
60%
Prevalence
40%
Genetics
20%
Factor V Leiden
20%
Oral Contraceptive Use
20%
Neuroscience
Antiphospholipid Syndrome
100%
Janus Kinase 2
100%
Cerebral Venous Sinus Thrombosis
100%
Prothrombin
60%
Blood Clotting Factor 5 Leiden
20%
Hemocyte
20%